This site is not intended for U.S. audiences

Browse the GSK Product Finder by:

GSK Product Name Generic Product Name
Text Size
Increase font size Decrease font size

PandemrixH1N1 Vaccine(H1N1)

H1N1 Vaccine

pandemic influenza vaccine (H1N1)

How To Use Demo

This animation is available to demonstrate "How to administer" GlaxoSmithKline's H1N1 vaccines. Governments can use this animation to support the training they are giving health care professionals

IMPORTANT NOTE: GSK manufactures and supplies two different adjuvanted pandemic H1N1 vaccines – Pandemrix ™ and Arepanrix™, both of which are presented as multi-dose vials of separate antigen and adjuvant which must be mixed together prior to use. The following animated demonstrations are intended for healthcare professionals as guidance on the correct method of preparation and administration of the vaccine. It is important to select the video which corresponds to the vaccine which you are using – either Pandemrix ™ or Arepanrix™.

Additionally, in some countries, at the request of the relevant regulatory authority, the multi-dose vaccine vials are supplied together with stickers for insertion in individual patients’ notes to assist healthcare professionals’ record-keeping and for identification of vaccine lot numbers used for each patient. Separate videos are available for healthcare professionals using vaccine supplied with, and without these stickers.

Please select the demonstration appropriate to the vaccine you are using:
Pandemrix™ with stickers
Pandemrix™ without stickers
Arepanrix™ without stickers

Pandemrix ™ (H1N1) is a clear light opalescent liquid.

Pandemrix ™ (H1N1) with stickers

It appears you don't have the correct Flash Player. Click the link below to download it.



Pandemrix ™ (H1N1) without stickers

It appears you don't have the correct Flash Player. Click the link below to download it.



Arepanrix ™ (H1N1) without stickers

It appears you don't have the correct Flash Player. Click the link below to download it.



For full instructions on how to administer Pandemrix ™ (H1N1) please see the Pandemrix ™ (H1N1) Summary of Product Characteristics (SPC)

Pandemrix

GSK statement

24 Nov 2009: Voluntary hold of Arepanrix (adjuvanted H1N1 pandemic vaccine) lot number A80CA007A in Canada